2022
An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol
Garakani A, Freire RC, Buono FD, Thom RP, Larkin K, Funaro MC, Salehi M, Perez-Rodriguez MM. An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol. PLOS ONE 2022, 17: e0269772. PMID: 35709149, PMCID: PMC9202921, DOI: 10.1371/journal.pone.0269772.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSelective serotonin reuptake inhibitorsSerotonin-norepinephrine reuptake inhibitorsUse of antipsychoticsLong-term riskAnxiety disordersReuptake inhibitorsUmbrella reviewSide effectsPanic disorderSystematic reviewNon-antipsychotic medicationsUse of quetiapineFirst-line treatmentSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitorsEvidence of efficacyCommon psychiatric disordersTraditional pharmacologic treatmentTreatment of anxietyAdjunctive treatmentPharmacologic treatmentTricyclic antidepressantsAntipsychoticsPsychiatric disordersSocial anxiety disorder
2002
Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder
Marshall RD, Garakani A. Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder. Psychiatric Clinics Of North America 2002, 25: 385-395. PMID: 12136506, DOI: 10.1016/s0193-953x(01)00005-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsBaseline cortisolLow baseline cortisolChronic PTSDDevelopment of PTSDStartle responseChronic medical conditionsBrief psychosocial interventionStandard of careAcute PTSD symptomsHPA axis functioningPost-traumatic eventsPost-traumatic stress disorderNormal circadian rhythmAcute stress reactionsEtiology of PTSDAcute stress responseLevel of symptomatologyAcute settingPharmacologic treatmentPharmacologic interventionsEtiologic roleSerial assessmentPersistent alterationsMedical conditionsStria terminalis